0001209191-20-033431.txt : 20200602
0001209191-20-033431.hdr.sgml : 20200602
20200602151217
ACCESSION NUMBER: 0001209191-20-033431
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200601
FILED AS OF DATE: 20200602
DATE AS OF CHANGE: 20200602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kasparian Michael
CENTRAL INDEX KEY: 0001813407
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21433
FILM NUMBER: 20936761
MAIL ADDRESS:
STREET 1: C/O FORRESTER RESEARCH
STREET 2: 60 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FORRESTER RESEARCH, INC.
CENTRAL INDEX KEY: 0001023313
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ENGINEERING, ACCOUNTING, RESEARCH, MANAGEMENT [8700]
IRS NUMBER: 042797789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 6176136000
MAIL ADDRESS:
STREET 1: 60 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: FORRESTER RESEARCH INC
DATE OF NAME CHANGE: 19960919
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-06-01
0
0001023313
FORRESTER RESEARCH, INC.
FORR
0001813407
Kasparian Michael
C/O FORRESTER RESEARCH, INC.
60 ACORN PARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Information Officer
Common Stock
3161
D
Non-Qualified Stock Option (Right to Buy)
38.43
2018-08-01
2024-07-31
common stock
300
D
Non-Qualified Stock Option (Right to Buy)
33.16
2019-08-03
2025-08-02
common stock
1476
D
Restricted Stock Units
2020-08-01
common stock
1112
D
Restricted Stock Units
2021-08-01
common stock
593
D
Restricted Stock Units
2022-08-01
common stock
383
D
Restricted Stock Units
2021-03-01
common stock
250
D
Restricted Stock Units
2022-03-01
common stock
250
D
Restricted Stock Units
2023-03-01
common stock
250
D
Restricted Stock Units
2020-09-03
common stock
290
D
On August 1, 2016, the reporting person was granted 2079 Restricted Stock Units and on August 1, 2017 the reporting person was granted 841 Restricted Stock Units that in each case vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
Each Restricted Stock Unit is the equivalent of one share of Forrester Research, Inc. common stock.
On August 1, 2017, the reporting person was granted 841 Restricted Stock Units and on August 1, 2018 the reporting person was granted 1533 Restricted Stock Units that in each case vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
On August 1, 2018 the reporting person was granted 1533 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
On March 1, 2019 the reporting person was granted 1000 Restricted Stock Units that in each case vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
On September 3, 2019 the reporting person was granted 580 Restricted Stock Units that in each case vest and convert into common stock in two equal and consecutive installments. The first installment on September 3, 2019 and the second installment on the first anniversary of the grant date.
Maite Garcia, attorney-in-fact for Michael Kasparian
2020-06-02
EX-24.3_919032
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
I hereby constitute and appoint each of Ryan Darrah, Maite Garcia and Jed
Rosenkrantz signing singly, my true and lawful attorney-in-fact to:
(1) execute for and on my behalf, in my capacity as an officer and/or director
of Forrester Research, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on my behalf that may be necessary
or desirable to complete and execute any such Form 3, 4 or 5 and timely file
such form with the United States Securities and Exchange Commission and any
stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be to my benefit,
in my best interest, or that I am legally required to do, it being understood
that the documents executed by such attorney-in-fact on my behalf pursuant to
this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's
discretion.
I hereby grant to such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper
to be done in the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as I might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. I acknowledge that the
attorney-in-fact, in serving in such capacity at my request, are not assuming,
nor is the Company assuming, any of my responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until I am no
longer required to file Forms 3, 4 and 5 with respect to my holdings of and
transactions in Company securities, unless I earlier revoke it in a signed
writing delivered to the attorneys-in-fact. Upon signature of this Power of
Attorney, I hereby revoke all previous powers of attorney granted concerning the
subject matter herein.
IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of
this 26th day of May, 2020.
Signature
/s/Michael Kasparian
Michael Kasparian
Print Name